None listed
Conditions
Interventions
Intervention1: Coenzyme Q10 Topical Gel (1 mg/gm).: Gently apply 2 FTU of the product (1.0 g) to cleansed face & neck twice a day. Massage in an upward motion until fully absorbed.Product will be appl
Sponsors
Inventia Healthcare Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntary women with moderate wrinkles (not greater than 2- 3 fine lines extending upto lateral end of eyebrow, but not beyond). 2. Age Limit: 35 â?? 55 years. 3. Has been fully informed verbally and in writing and comply with the study specifications. Signature for participation in test. 4. Photo type: III (White skin which sometimes burns, difficult to tan) and IV (Moderate brown skin which rarely burns and tans with ease). 5. Accepting not to use products with same end benefit, or containing sunscreen, during the study. 6. Co-operating, informed of the need and duration of the examinations. 7. For which the Investigator considers that the compliance will be correct.
Exclusion criteria
Exclusion criteria: 1. Skin allergy antecedents or atopic subject. 2. Pregnant women (as confirmed by UPT) and lactating women. 3. Seasonal allergies/Hyper sensitivity to any cosmetic product. 4. Any clinically significant systemic or cutaneous disease, which may interfere with study treatments or procedure. 5. Subjects on any medical treatment either systemic/topical in the past 1 month which may interfere with the performance of the study treatment. 6. Subject in an exclusion period or participating in any other similar cosmetic or therapeutic trial as identified during screening on visit 1 (V1).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Primary Evaluation criteria (Primary Objective) for this study: â?¢ Measuring depth of wrinkles around crowâ??s feet area using PRIMOS â?¢ Hydration of Stratum corneum by MoistureMeter SC â?¢ Cutometer measurements for elasticity and firmness. The Secondary Evaluation Criteria (Primary Objective) for this study: â?¢ Self evaluation questionnaire to evaluate the product efficacy and sensorial properties. â?¢ Clinical Evaluation using skin age score. Timepoint: The Primary Evaluation criteria (Primary Objective) : â?¢ Measuring depth of wrinkles using PRIMOS on Day 0 and Day 30. â?¢ Hydration by MoistureMeter SC on Day 0, 15 and 30. â?¢ Cutometer measurements for elasticity and firmness on Day 0, 15 and 30. The Secondary Evaluation Criteria (Primary Objective) : â?¢ Self evaluation questionnaire to evaluate the product efficacy and sensorial properties on Day 15 and 30. â?¢ Clinical Evaluation using skin age score on Day 0, 15 and 30. | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Clinical Evaluation for toleranceTimepoint: Day 15 and Day 30 | — |
Countries
India
Contacts
Public ContactDr Ganeshchandra Sonavane
Outcome results
None listed